Trials / Withdrawn
WithdrawnNCT03048461
The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia
A Randomized, Double-blind, Placebo-controlled Clinical Trial Investigating the Effect of Autologous Platelet-rich Plasma in Subjects With Androgenetic Alopecia.
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Northwestern University · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of autologous platelet-rich plasma (PRP) in the treatment of androgenetic alopecia. This is a randomized clinical trial to evaluate the effect of autologous platelet rich plasma in subjects with moderate androgenetic alopecia. Approximately 30 subjects will be randomized into the study. The study is designed as an 18-month study consisting of 2 phases. This study was a pilot study designed to determine feasibility of this procedure. Subjects currently living in the Chicago metropolitan area and meet inclusion/exclusion criteria will be considered for enrollment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Platelet Rich Plasma Prep System | intradermal injections of platelet rich plasma to an area of alopecia |
| DRUG | Placebo | intradermal injections to an area of alopecia |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2020-12-01
- Completion
- 2020-12-01
- First posted
- 2017-02-09
- Last updated
- 2021-12-23
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03048461. Inclusion in this directory is not an endorsement.